Citigroup’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$298K Sell
26,230
-48,390
-65% -$549K ﹤0.01% 3171
2025
Q1
$496K Buy
74,620
+16,487
+28% +$110K ﹤0.01% 2949
2024
Q4
$641K Buy
58,133
+32,467
+126% +$358K ﹤0.01% 2862
2024
Q3
$315K Buy
25,666
+10,522
+69% +$129K ﹤0.01% 3292
2024
Q2
$205K Buy
15,144
+9,678
+177% +$131K ﹤0.01% 3144
2024
Q1
$73.8K Buy
5,466
+1,494
+38% +$20.2K ﹤0.01% 3693
2023
Q4
$20.9K Buy
3,972
+3,372
+562% +$17.7K ﹤0.01% 4221
2023
Q3
$2.36K Sell
600
-8,868
-94% -$34.9K ﹤0.01% 4168
2023
Q2
$101K Buy
9,468
+8,623
+1,020% +$91.7K ﹤0.01% 3578
2023
Q1
$7.04K Sell
845
-197
-19% -$1.64K ﹤0.01% 4178
2022
Q4
$9.62K Sell
1,042
-152
-13% -$1.4K ﹤0.01% 4144
2022
Q3
$15K Sell
1,194
-1,434
-55% -$18K ﹤0.01% 4127
2022
Q2
$35K Sell
2,628
-17,932
-87% -$239K ﹤0.01% 4010
2022
Q1
$433K Sell
20,560
-34,234
-62% -$721K ﹤0.01% 2946
2021
Q4
$1.32M Buy
54,794
+14,927
+37% +$358K ﹤0.01% 2291
2021
Q3
$1.01M Sell
39,867
-28,749
-42% -$731K ﹤0.01% 2384
2021
Q2
$2.31M Buy
68,616
+24,679
+56% +$831K ﹤0.01% 1999
2021
Q1
$1.71M Buy
43,937
+40,015
+1,020% +$1.55M ﹤0.01% 2028
2020
Q4
$243K Buy
3,922
+1,076
+38% +$66.7K ﹤0.01% 3126
2020
Q3
$95K Sell
2,846
-2,900
-50% -$96.8K ﹤0.01% 3170
2020
Q2
$137K Sell
5,746
-1,446
-20% -$34.5K ﹤0.01% 3273
2020
Q1
$165K Buy
7,192
+2,800
+64% +$64.2K ﹤0.01% 2976
2019
Q4
$124K Buy
4,392
+3,985
+979% +$113K ﹤0.01% 3398
2019
Q3
$9K Buy
+407
New +$9K ﹤0.01% 4624